The use of light therapy for tissue destruction is highly attractive for the endoscopic and minimally invasive therapy of esophageal cancer. Photodynamic therapy (PDT) offers the possibility of palliation of advanced obstructing tumors. However, there are other competing techniques, which can be used to open the esophageal lumen. It has also proved very effective in providing prolonged palliation of patients with advanced irresectable cancer. Completely obstructing tumors, tortuous and long lesions, and tumors near the upper end of the esophagus are particularly suitable for photodynamic therapy. Patients with obstruction to an esophageal prosthesis are also well palliated with PDT. A more interesting and exciting development is its use for the eradication of early asymptomatic mucosal disease. Photodynamic therapy is particularly useful for the eradication of field cancerous change in patients with pre-malignant Barrett's esophagus, or early tumors in patients unfit for radical therapy.
BarrH., Oesophageal Cancer Medicine26, 7–10 (1998).
2.
BlotW. J., DevesaS. S., KnellerR. W., FraumeniJ. F.Jr.. Rising Incidence of Adenocarcinoma of the Oesophagus and Gastric Cardia. JAMA.265, 1287–1289 (1991).
3.
WijnhovenB. P. L., SiersemaP. D., HopW. C. J., van DekkenH., TilanusH. W.Adenocarcinomas of the Distal Oesophagus and Gastric Cardia are one Clinical Entity. Br. J. Surg.86, 529–535 (1999).
PowellJ., McConkeyC. C.The Rising Trend in Oesophageal Adenocarcinoma and Gastric Cardia. Eur. J. Cancer Prev.1, 265–269 (1992).
6.
PoyntonA. R., WalshT. N., O'SullivanG., HennessyT. P. J.Carcinoma Arising in Familial Barrett's Esophagus. Am. J. Gastroenterol.91, 1855–1856 (1996).
7.
Van SandickJ. W., van LanschotJ. J. B., KuikenB. W., TytgatG. N. J., OfferhausG. J. A., ObertopH.Impact of Endoscopic Biopsy Surveillance of Barrett's Oesophagus on the Pathological Stage and Clinical Outcome of Barrett's Carcinoma. Gut43, 216–222 (1998).
8.
Van den Boogert, Van HillegersbergR., De BruinR. W. F., TilanusH. W., SiersemaP. D.Barrett's Oesophagus: Pathophysiology, Diagnosis, and Management. Scand. J. Gastroenterol.33, 449–453 (1998).
9.
LagergrenJ., BergstromR., LindrenA., NyrenO.Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma. N. Engl. J. Med.340, 825–831 (1999).
10.
JankowskiJ., PerryI., HarrisonR. F.Gastro-oesophageal Cancer: Death at the Junction. Brit. Med. J.322, 463–464 (2000).
11.
AckroydR., KeltyC., BrownN., ReedM.The History of Photodetection and Photodynamic Therapy. Photochem. Photobiol.74, 656–669 (2001).
12.
von TappeinerH.Zur kenntnis der lichwirkenden fluoreszierenden stoffe. Deutche. Med. Wschschr.1, 579–586 (1904).
13.
Meyer-BetzF.Untersuchungen uber die biologische (photody-namische) wirkung des hamatoporphyrins und anderer derivate des blut-ubd gallenfarbstoffs Deutsches. Arch. Fur. Klin. Med.112, 476–503 (1913).
14.
AulerH., BanzerG.Untersuchungen uber die rolle der porphyrine bei geschwulskranken menschen und tieren. Z. Krebsforsch53, 65–68 (1942).
15.
BarrH., DixA. J., KendallC., StoneN.The Potential for Photodynamic Therapy in the Management of Upper Gastrointestinal Disease. Alimentary Pharmacology & Therapeutics15, 311–321 (2001).
16.
DoughertyT. J.Activated Dyes as Antitumor Agents. J. Natl. Cancer Inst.52, 1333–1336 (1974).
17.
McCaughanJ. S., HicksW., LaufmanL., MayE., RoachR.Palliation of Esophageal Malignancy with Photoradiation Therapy. Cancer54, 2905–2910 (1984).
18.
KastingJ. F.The Rise of Atmospheric Oxygen. Science293, 819–820 (2001).
19.
BauerJ., ChenK., HiltbunnerA., WehrilE., EugsterM., SchnellD., KesslerF.The Major Protein Import Receptor of Plastids is Essential for Chloroplast Biogenesis. Nature403, 203–207 (2000).
20.
FulljamesC., StoneN., BennettD., BarrH.Beyond White Light Endoscopy: The Prospects for Endoscopic Optical Biopsy. Italian Journal of Gastroenterology and Hepatology31, 695–704 (1999).
21.
BarrH., TralauC. J., BoulosP. B., KrasnerN., ClarkC. G., BownS. G.Selective Destruction of Dimethyl-hydrazine Rat Colon Cancer Using Phthalocyanine Photodynamic Therapy. Gastroenterology98, 1532–1537 (1990).
22.
BarrH., TralauC. J., MacRobertA. J., MorrisonI., PhillipsD., BownS. G.Fluorescence Photometric Techniques for Determination of Microscopic Tissue Distribution of Phthalocyanine Photosensitisers for Photodynamic Therapy. Las. Med. Sci.3, 81–86 (1988).
23.
RegulaJ., MacRobertA. J., GorcheinA.Photosensitisation and Photodynamic Therapy of Oesophageal, Duodenal, and Colorectal Tumors using 5-aminolaevulinic Acid Induced Protoporphyrin IX-a Pilot Study. Gut36, 67 (1995).
24.
BarrH.Barrett's Esophagus: Treatment with 5-aminolevulinic Acid Photodynamic Therapy. Gastrointest. Endosc. Clin. North America10, 421–438 (2000).
25.
BarrH., ShepherdN. A., DixA., RobertsD. J. H., TanW. C., KrasnerN.Eradication of High Grade Dysplasia in Columnar-lined (Barrett's) Oesophagus using Photodynamic Therapy with Endogenously Generated Protoporphyrin IX. Lancet348, 584–585 (1996).
26.
BarrH.Gastrointestinal Tumors: Let There be Light. Lancet352, 1242–1244 (1998).
27.
AltorkiN. K., SunagawaM., LittleA. G., SkinnerD. B.High-grade Dysplasia in the Columnar-lined Esophagus. Am. J. Surg.161, 97–99 (1991).
28.
PeraM., TrastekV. F., CarpenterH. A., AllenM. S., DeschampsC., PairoleroP. C.Barrett's Esophagus with High-grade Dysplasia: An Indication for Esophagectomy?Ann. Thorac. Surg.54, 199–204 (1992).
29.
RiceT. W., FalkG. W., AchkarE., PetrasR. E.Surgical Management of High-grade Dysplasia in Barrett's Esophagus. Am. J. Surg.174, 1832–1836 (1997).
30.
SteitzJ. M.Jr., AndrewsC. W.Jr., EllisF. H.Jr.. Endoscopic Surveillance of Barrett's Oesophagus. Does it Help?J. Thorac. Cardiovasc. Surg.105, 383–388 (1993).
31.
BarrH.Endoscopic Screening for Upper Gastrointestinal Cancer in Therapeutic Gastrointestinal Endoscopy. A Problem-oriented Approach. pp53–66. eds., WestabyD. & LombardM., Martin Dunitz Taylor & Francis Books (2002).
32.
BarrH., TanW. C., ShepherdN. A.Photodynamic Therapy (PDT) using 5-aminolaevulinic Acid (5-ALA) for Oesophageal Adenocarcinoma Associated with Barrett's Metaplasia. Las. Med. Sci.4, 9 (1997).
33.
HauserT., SzeimiesR. M., ScholmerichJ.Side Effects of 5-aminolevulinic Acid Photosensitization in Photodiagnosis of Precancerous Lesions of the Gastrointestinal Tract. Gastroenterology114, G3092 (1999).
34.
LightdaleC. J.Role of Photodynamic Therapy in the Management of Advanced Esophageal Cancer. Gastrointest. Endosc. Clin. North America10, 397–408 (2000).
35.
RaduA., WagnieresG., van den BergH., MonnierP.Photodynamic Therapy of Early Squamous Cell Cancers of the Esophagus. Gastrointest. Endosc. Clin. North America10, 439–460 (2000).
36.
StrokaR., BeyerW., KrugM.Laser Light Application and Light Monitoring for Photodynamic Therapy in Hollow Organs. Las. Med. Sci.8, 67 (1993).
37.
PanjehpourM., OverholtB. F., HaydekJ. M.Light Sources and Delivery Devices for Photodynamic Therapy in the Gastrointestinal Tract. Gastrointest. Endosc. Clin. North America10, 513–532 (2000).
38.
OverholtB. F., DeNovoR. C., PanjehpourM.A Centering Balloon for Photodynamic Therapy of Esophageal Cancer Tested in a Canine Model. Gastrointest. Endosc.39, 782 (1993).
39.
LaunoisB., PaulJ. L., LygidakisN. J.Results of Surgical Treatment of Carcinoma of the Oesophagus. Surg. Gynaecol. Obstet.136, 750–753 (1983).
40.
CunninghamD., HoleD., TaggartD. J., SoukopM., CarterD. C., McArdleC. S.Evaluation of the Prognostic Factors in Gastric Cancer: The Effect of Chemotherapy on Survival. Br. J. Surg.74, 715–720 (1987).
41.
BarrH.Endoscopic Treatment of Upper Gastrointestinal Cancer. Current Medical Literature Gastroenterology18, 61–66 (1999).
42.
SykesN. P., BainesM., CarterR. L.Clinical and Pathological Study of Dysphagia Conservatively Managed in Patients with Advanced Malignant Disease. Lancet726–728.
43.
BoyceW. C.Jr.. Palliation of Advanced Esophageal Cancer. Seminars in Oncology11, 186–195 (1988).
BownS. G.Palliation of Malignant Dysphagia: Surgery, Radiotherapy, Intubation Alone or in Combination. Gut32, 841–844 (1991).
49.
ShumueliE., MyszorM. F., BurkeD., RecordC. O., MatthewsonK.Limitations of Laser Treatment for Malignant Dysphagia. Br. J. Surg.79, 778–780 (1992).
50.
WrightR. A., O'ConnorK. W.A Pilot Study of Endoscopic Injection Chemo/sclerotherapy of Esophageal Carcinoma. Gastrintest. Endosc.36, 47–48 (1990).
51.
Payne-JamesJ. J., SpillerR. C., MisiewiczJ. J., SilkD. B. A.Use of Ethanol-induced Tumor Necrosis to Palliate Dysphagia in Patients with Esophagogastric Cancer. Gastrointest. Endosc.36, 43–46 (1990).
52.
SpencerG. M., ThorpeS. M., SargeantI. R., BlackmanG. M., SolanoJ., TobiasJ. S.Laser and Brachytherapy in Palliation of Adenocarcinoma of the Oesophagus and Cardia. Gut39, 726–731 (1996).
53.
ShumeliE., SrivastavaE., DawesJ. D. H., ClaqueM., MatthewsonK., RecordC. O.Combination of Laser Treatment and Intraluminal Radiotherapy for Malignant Dysphagia. Gut38, 803–805 (1996).
54.
ThomasR. J., AbbottM., BhathalP. S.High Dose Photoradiation Therapy of Esophageal Cancer. Ann. Surg.206, 193 (1987).
55.
SchweitzerV. G., BolognaW. C. J., BatraS. K.Photodynamic Therapy for Treatment of Esophageal Cancer: A Preliminary Report. Laryngoscope103, 699 (1993).
56.
HeierS. K.Photodynamic Therapy for Esophageal Malignancies in Advanced Therapeutic Endoscopy2nd Edition pp 57–65 Ed. BarkinJ. S., O'PhelanC. A.Raven PressNew York (1994).
57.
HeierS. K., RothmanK. A., HeierL. M., RosenthalW. S.Photodynamic Therapy for Obstructing Esophageal Cancer: Light Dosimetry and a Randomized Comparison with Nd:YAG Laser Therapy. Gastroenterology109, 63–72 (1995).
58.
MoghissiK., DixonK., ThorpeJ. A. C., StringerM., MooreP. J.The Role of Photodynamic Therapy in Inoperable Oesophageal Cancer. Eur J. Cardiothorac. Surg.17, 95–100 (2000).
GasparriG., CasalengoP. A., CamadonaM.Endoscopic Insertion of 248 Prosthesies in Inoperable Carcinoma of the Oesophagus and Cardia: Short and Long-term Results. Gastrointest. Endosc.33, 354–356 (1987).
61.
FuggerR., NiederleB., JantschH., SchiesselR., SchultzR.Endoscopic Tube Implantation for the Palliation of Malignant Esophageal Stenosis. Endoscopy22, 101–104 (1990).
SiersemaP. D., HopW. C. J., TilanusH. W., van BlankensteinM., DeesJ.Coated Expandable Metal Stents Versus Conventional Prostheses for Inoperable Carcinoma of Esophagus and Cardia: A Controlled Prospective Study. Gastroenterology112, A656 (1997).
64.
KnyrimK., WagnerH.-J., BethgeN., KeymlingM., VakilN.A Controlled Trial of an Expansile Metal Stent for Palliation of Esophageal Obstruction Due to Inoperable Cancer. N. Engl. J. Med.329, 1302–1307 (1993).
65.
BarrH.Laser Application. In Atlas of Gastrointestinal Endoscopy pp. 284–289. Ed Classen, Tytgat, Lightdale (2002).
66.
LowD. E., PaglieroK. M.Prospective Randomized Clinical Trial Comparing Brachytherapy and Laser Photoablation for Palliation of Esophageal Cancer. J. Thorac. Cardiovasc. Surg.104, 173–9 (1992).
67.
SpencerG. M., ThorpeS. M., BlackmanG. M., SolanoJ., TobiasJ. S., LovatL. B., BownS. G.Laser Augmented by Brachytherapy Versus Laser Alone in the Palliation of Adenocarcinoma of the Oesophagus and Cardia: ARandomized Study. Gut50, 224–227 (2002).
68.
LightdaleC. J., HeierS. K., MarconN. E., McCaughanJ. S., GerdesH., OverholtB. F., SivakM. V., SteigmannG. V., NavaH. R.Photodynamic Therapy with Porfimer Sodium Versus Thermal Ablation Therapy with Nd:YAG Laser for Palliation of Esophageal Cancer: A Multicenter Randomized Trial. Gastrointest. Endosc.42, 507–512 (1995).
69.
BarrH.Management of Gastrointestinal Lesions with Malignant Potential Endoscopic Techniques for Palliation: Laser Techniques in Update Gastroenterology 2001 Recent Advances in Gastrointestinal Oncology pp101–108. Ed Tytgat & Lundell (2001).
70.
McCaughanJ. S., WilliamsT. E., BethelB. H.Palliation of Esophageal Malignancy with Photodynamic Therapy. Ann. Thorac. Surg.40, 113–119 (1985).
71.
McCaughanJ. S., ThomasA., GuyJ. T., HicksW. J., WilliamsT. E., LaufmanL. R.Photodynamic Therapy for Esophageal Tumors. Arch. Surg.124, 74–80 (1989).
72.
MaierA., TomaselliF., AneggU., FehakP., FellB., LuznikS., PinterH., Smolle-JuttnerF. M.Combined Photodynamic Therapy and Hyperbaric Oxygenation in Carcinoma of the Esophagus and the Esophago-gastric Junction. Eur. J. Cardiothorac. Surg.18, 649655 (2000).
73.
LoganP. M., NewtonJ., RichterA., YipS., LevyJ. G.Immunological Effects of Photodynamic Therapy. SPIE1203, 153–158 (1990).
74.
EvansS., MatthewsW., PerryR., FrakerD., NortonJ., PassH. I.Effect of Photodynamic Therapy on Tumor Necrosis Factor Production by Murine Macrophages. J. Nat. Cancer Inst.82, 34–39 (1990).
75.
LuketichJ. D., ChristieN. A., BuenaventuraP. O., WeigelT. L., KeenanR. J., Nguyen. Endoscopic Photodynamic Therapy for Obstructing Esophageal Cancer: Cases Over a 2 Year Period. Surg. Endosc.14, 633–657 (2000).
76.
HirotaW. K., LoughneyT. M., LazasD. J., MaydonovitchC. L., RhollV., WongR. K. H.Specialised Intestinal Metaplasia, Dysplasia, and Cancer of the Esophagus and Esophagogastric Junction: Prevalence and Clinical Data. Gastroenterology118, 277–285 (1999).
77.
LevineD. S., HaggittR. C., BlountP. L., RabinovitchP. S., RuschV. W., ReidB. J.An Endoscopic Biopsy Protocol Can Differentiate High-grade Dysplasia from Early Adenocarcinoma in Barrett's Esophagus. Gastroenterology105, 40–50 (1993).
78.
PetersJ. H., ClarkG. W. B., IrelandA. P., ChandrasomaP., SmyrkT. C., DeMeesterT. R.Outcome of Adenocarcinoma Arising in Barrett's Esophagus in Endoscopically Surveyed and Nonsurveyed Patients. Thorac. Cardiovasc. Surg.108, 813–822 (1994).
79.
GrosjeanP., MonnierP.Photodynamic Therapy and Mucosectomy for Early Squamous Cell Carcinomas in the Oesophagus and Tracheobronchial Tree. Eur. J. Surg. Oncol.24, 234 (1998).
80.
80. HeitmillerRF, RedmondM, HamiltonSRBarrett's esophagus with high grade dysplasia, an indication for prophylactic esophagectomy. Ann. Surg.224, 66–71 (1996).
81.
CameronA. J., CarpenterH. A.Barrett's Oesophagus, High-grade Dysplasia, and Early Adenocarcinoma: A Pathological Study. Am. J. Gastroenterol.92, 586–591 (1997).
SchlemperR. J., ItabashiM., KatoY.Differences in Diagnostic Criteria for Gastric Carcinoma Between Japanese and Western Pathologists. Lancet347, 1725–1729 (1997).
84.
SibilleA., LambertR., SouquetJ.-C., SabbenG., DescosF.Long-term Survival After Photodynamic Therapy for Esophageal Cancer. Gastroenterology108, 3378–344 (1995).
85.
PatriceT., FoultierM. T., YactayoS., AdamF., GalmicheJ. P., DouetM. C., Le BodicL.Endoscopic Photodynamic Therapy with Hematoporphyrin Derivative for Primary Treatment of Gastrointestinal Neoplasms in Inoperable Patients. Dig. Dis. Sci.35, 545–552 (1990).
86.
HochainP., DucrotteP., PaillotB., TouchaisJ.-Y., ThorelJ.-M., PetitA., OuvryD., HecketsweilerP.La Phototherapie Dynamique par Laser a Colorant. Gastroenterol. Clin. Biol.16, 552–557 (1992).
87.
SpinelliP., ManciniA., Dal FanteM., MeroniE.Photodynamic Therapy of Early Stage Esophageal Carcinoma: Results and Survival. Proceedings of International Photodynamic Association (1996).
88.
CortiL., SkarlatosJ., BosoC., CardinF., KosmaL., KoukourakisM. I., GiatromanolakiA., NorbertoL., SafferM., BeroukasK.Outcome of Patients Receiving Photodynamic Therapy for Early Esophageal Cancer. Int. J. Radiation Oncology Biol. Phys.47, 419–424 (2000).
89.
HayataY., KatoH., FuruseK., KusumokiY., SukukiS., MimuraS.Photodynamic Therapy of 168 Early Stage Cancers of the Lung and Oesophagus: A Japanese Multicenter Study. Las. Med. Sci.11, 255–259 (1996).
90.
OverholtB. F., PanjehpourM., HaydekJ. M.Photodynamic Therapy for Barrett's Esophagus: Follow-up in 100 Patients. Gastrointest. Endosc.49, 1–7 (1999).
91.
RaduA., WagnieresG., van den BergH., MonnierP.Photodynamic Therapy of Early Squamous Cell Cancers of the Esophagus. Gastrointestinal Endoscopy Clinics of North America10, 439–460 (2000).
92.
SavaryJ. F., GrosjeanP., MonnierP.Photodynamic Therapy for Early Squamous Cell Carcinomas of the Esophagus: AReview of 31 Cases. Endoscopy30, 258–265 (1998).
93.
GossnerL., MayA., PechO., RabensteinT., SchneiderH. T., HahnE. G., StolteM., EllC.Photodynamic Therapy of Barrett's Esophagus with Dysplasia or Early Cancer. Gastroenterology116, G1811 (1999).
94.
GrosjeanP., SavaryJ. F., WagnieresG., MizeretJ., WoodtliA., TheumannJ.-F., FontollietC., van den BergH., MonnierP.Tetra(m-hydroxyphenyl) Chlorin Clinical Photodynamic Therapy of Early Bronchial and Oesophageal Cancers. Las. Med. Sci.11, 227235 (1996).
95.
GossnerL., StolteM., StrokeR.Photodynamic Therapy of High-grade Dysplasia and Early Stage Carcinomas by Means of 5-aminolaevulinic Acid. Gastroenterology114, 447–455 (1998).
96.
AckroydR., BrownN. J., DaviesM. F., StephensonT. J., StoddardC. J., ReedM. W. R.Aminolaevulinic Acid-induced Photodynamic Therapy in the Treatment of Dysplastic Barrett's Oesophagus and Adenocarcinoma. Las. Med. Sci.14, 278–285 (1999).
97.
TanW. C., FulljamesC., StoneN., DixA. J., ShepherdN., RobertsD. J. H., BrownS. B., KrasnerN., BarrH.Photodynamic Therapy Using 5-aminolaevulinic Acid for Oesophageal Adenocarcinoma Associated with Barrett's Metaplasia. J. Photochem. Photobiol. B.53, 75–80 (1999).
98.
Van den BoogertJ., Van HillegersbergR., De RooijF. W. M., De BruinR. W. F., Edixhoven-BosdijkA., HoutsmullerA. B., SiersemaP. D., WilsonJ. H. P., TilanusH. W.5-aminolaevulinic Acid-induced Protoporphyrin Accumulation in Tissues: Pharmacokinetics After Oral or Intravenous administration. J. Photochem. Photobiol. B.44, 29–38 (1998).
99.
Van den BoogertJ., HoutsmullerA. B., De RooijF. W. M., De BruinR. W. F., SiersemaP. D., Van HillegersbergR.Kinetics, Localization, and Mechanism of 5-aminolaevulinic Acid-induced Porphyrin Accumulation in Normal and Barrett's-like Rat Esophagus. Las. Surg. Med.24, 3–13 (1999).
100.
Van den BoogertJ., Van HillegersbergR., Van StaverenH. J., De BruinR. W. F., SiersemaP. D., TilanusH. W.Timing of Illumination is Essential for Effective and Safe Photodynamic Therapy: A Study in the Normal Rat Oesophagus. Brit. J. Cancer79, 825–830 (1999).
101.
Van den BoogertJ., van StaverenH. J., De BruinR. W. F., SiersemaP. D., HillegersbergR.Fractionated Illumination for Oesophageal ALA-PDT: Effect on Blood Flow and PpIX Formation. Las. Med. Sci.16, 16–25 (2001).
102.
AckroydR., DavisM. F., StephensonT. J.Photodynamic Therapy for Barrett's Oesophagus: A Prospective Randomized Trial. Endoscopy29, E17 (1997).
OrtnerM., ZumbuschK., LiebetruthJ.Photodynamic Therapy in Barrett's Esophagus After Local Administration of 5-aminolaevulinic Acid. Gastroenterology112, A633 (1997).
105.
WangK. K., GellerA.Photodynamic Therapy for Early Esophageal Cancers: Light Versus Surgical Might. Gastroenterology108, 593–607 (1995).
106.
OverholtB., PanjehpourM., TefftellarE.Photodynamic Therapy for the Treatment of Early Carcinoma in Barrett's Esophagus. Gastrointest. Endosc.39, 73–76 (1993).
107.
WangK. K., SongL. M. Wong Kee, NourbakhshCan Consistent Tissue Necrosis be Achieved During Photodynamic Therapy for High-grade Dysplasia or Cancer within Barrett's Esophagus?Gastroenterology112, A676 (1997).
108.
SpinelliP., Dal FanteM., ManciciA.Endoscopic Photodynamic Therapy of Early Cancer and Severe Dysplasia of the Esophagus. In Photodynamic Therapy and Biomedical Lasers pp262–265 eds. SpinelliP., Dal FanteM., MarchesiniR., Amsterdam: Elsevier Science Inc (1992).
109.
OverholtB. F., HaggittR. C., BronnerP., TaylorS. L., YongH., ColinP., SpenardJ.A Multicenter, Partially Blinded, Randomized Study of the Efficacy of Photodynamic Therapy (PDT) Using Porfimer Sodium (POR) for Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE): Results of 6 Month Follow-up. Gastroenterology120, A77 (2001).
110.
RagunathK., KrasnerN., RamanV. S., HaqqaniM. T., PhillipsC. J., CheungW. Y.Endoscopic Ablation of Dysplastic Barrett's Oesophagus Comparing Argon Plasma Coagulation and Photodynamic Therapy: Short Term Results of a Randomized Prospective Trial. British Medical Laser Annual Conference (2002).
